Can AI see what doctors miss?? From researcher to startup founder: Olga Kubassova
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
Can AI see what doctors miss?? From researcher to startup founder: Olga Kubassova
-
ナレーター：
-
著者：
このコンテンツについて
💊 90% of drugs fail. Clinical trials take years. And billions are lost every time.
In this episode of Founders & Builders, I sit down with Dr. Olga Kubassova, a mathematician turned biotech investor, and founder of Image Analysis Group — a company using AI-powered imaging biomarkers to reinvent how we measure whether a drug is actually working.
We cover:
🧠 Why clinical trials are broken — and what needs to change
📉 How AI biomarkers let us see disease earlier and treatment faster
⚙️ What makes a billion-dollar drug fail — and how we can spot it sooner
💡 Olga’s journey from math PhD to advising governments and top pharma
🏥 The future of precision medicine and data-driven trials
One of my favorite moments:“If you can see disease earlier and measure treatment faster — that’s the difference between a failed drug and a billion-dollar success.”
This is a conversation about the future of medicine — and how AI is changing everything.